Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates
Michael B. Fallon(University of Arizona), Steven M. Kawut(Hospital of the University of Pennsylvania), Keith Wille(University of Alabama at Birmingham), Neil Kaplowitz(University of Southern California), Vijay H. Shah(Mayo Clinic in Arizona), Steven Zacks(University of North Carolina at Chapel Hill), Robert S. Brown(Cornell University), Lisa Forman(Center for Clinical Research (United States)), Kari E. Roberts(Tufts Medical Center), James F. Trotter(Baylor Scott & White Health), Michael J. Krowka(Mayo Clinic)
Cited by 306
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
The association between hepatitis C infection and survival after orthotopic liver transplantation
|Gastroenterology|2002|1k
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837